Certified by Founder
Lodge
PQShield
start up
United Kingdom
- Oxford, England
- 26/01/2022
- Series A
- $20,000,000
Formed as a spinout of the University of Oxford by cryptography researchers and specialists, PQShield has unrivalled domain expertise in the design and implementation of quantum-resistant cryptography for software and hardware applications.
PQShield is a major contributing participant to the National Institute of Standards and Technology (NIST) Post-Quantum Standardisation Process.
At PQShield, we help customers transition their product lines from legacy RSA and Elliptic Curve cryptography to quantum-secure standards by offering ready-made and tailored IP for secure elements, IoT firmware, PKI and server technologies, and end-user applications."
- Industry Computer & Network Security
- Website https://pqshield.com/
- LinkedIn https://www.linkedin.com/company/pqshield/about/
Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)